Use of medicines and health services for chronic obstructive pulmonary disorder in Australia
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Presentation
- By: LIM, Renly (University of South Australia, Australia)
- Co-author(s): Renly Lim
Mhairi Kerr: Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, Australia
Elizabeth Roughead: Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, Australia
Chronic obstructive pulmonary disease (COPD) is a major public health problem affecting one in twenty Australians aged 45 years and older. The Australian guideline provides recommendations on use of COPD medicines and health services to optimise function, prevent deterioration and manage exacerbation.
The cross-sectional.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.